Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Cancer Immunology Research|June 9, 2022
Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder CancerShingo Tsuji, Katherine Reil, Kinsey Nelson, et al.
BMC Surgery|May 8, 2016
Clinical score to predict the risk of bile leakage after liver resectionTakahiro Kajiwara, Yutaka Midorikawa, Shintaro Yamazaki, et al.
Journal for Immunotherapy of Cancer|June 8, 2023
Intralesional administration of VAX014 facilitates in situ immunization and potentiates immune checkpoint blockade in immunologically cold tumorsKatherine A Reil, Shingo Tsuji, Elsa Molina, et al.
Bioscience Trends|October 1, 2020
Comparison of the surgical outcomes in patients with synchronous versus metachronous multiple hepatocellular carcinomaYutaka Midorikawa, Tadatoshi Takayama, Tokio Higaki, et al.
Journal of Gastroenterology|May 22, 2009
Restoration of gut motility in Kit-deficient mice by bone marrow transplantationShuji Ishii, Shingo Tsuji, Masahiko Tsujii, et al.
Bioscience Trends|July 28, 2020
High platelet count as a poor prognostic factor for liver cancer patients without cirrhosisYutaka Midorikawa, Tadatoshi Takayama, Tokio Higaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 30, 2018
Liver resection for recurrent hepatocellular carcinoma after radiofrequency ablation therapyShunsuke Yamagishi, Yutaka Midorikawa, Hisashi Nakayama, et al.
Journal of Hepatology|October 16, 2012
Marginal survival benefit in the treatment of early hepatocellular carcinomaYutaka Midorikawa, Tadatoshi Takayama, Kazuaki Shimada, et al.
Pageof 11